Connecting you to content on EBSCOhost

Works by Shi, Michael M.

Results: 3

1

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Published in:

Cancer Science, 2011, v. 102, n. 4, p. 845, doi. 10.1111/j.1349-7006.2010.01839.x

By:

Hida, Toyoaki;
Tamiya, Motohiro;
Nishio, Makoto;
Yamamoto, Nobuyuki;
Hirashima, Tomonori;
Horai, Takeshi;
Tanii, Hiromi;
Shi, Michael M.;
Kobayashi, Ken;
Horio, Yoshitsugu

Publication type:

Article

2

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy.

Published in:

2017

By:

Musolino, Antonino;
Campone, Mario;
Neven, Patrick;
Denduluri, Neelima;
Barrios, Carlos H.;
Cortes, Javier;
Blackwell, Kimberly;
Soliman, Hatem;
Kahan, Zsuzsanna;
Bonnefoi, Hervé;
Squires, Matthew;
Zhang, Yong;
Deudon, Stephanie;
Shi, Michael M.;
André, Fabrice

Publication type:

journal article

3

BRAF Polymorphisms and Risk of Melanocytic Neoplasia.

Published in:

Journal of Investigative Dermatology, 2005, v. 125, n. 6, p. 1252, doi. 10.1111/j.0022-202X.2005.23937.x

By:

James, Michael R.;
Roth, Richard B.;
Shi, Michael M.;
Kammerer, Stefan;
Nelson, Matthew R.;
Stark, Mitchell S.;
Dumenil, Troy;
Montgomery, Grant W.;
Hayward, Nicholas K.;
Martin, Nicholas G.;
Braun, Andreas;
Duffy, David L.

Publication type:

Article